Amicus' fourth-quarter 2024 earnings miss estimates while revenues beat the same.

RARE reports mixed fourth-quarter results, as earnings miss estimates while revenues beat the same. Product sales increase year over year.

Intra-Cellular reports mixed fourth-quarter 2024 results, wherein earnings miss estimates but revenues beat the same driven by strong Caplyta sales.

CENX earnings beat estimates in the fourth quarter on higher aluminum prices.

ALNY reports better-than-expected fourth-quarter results as both earnings and revenues beat estimates driven by higher product sales.

OGE's fourth-quarter revenues beat the Zacks Consensus Estimate by 13.1%. The top line also increases 34.2% from the year-ago level.

BLKB reports fourth-quarter results, with the top line missing estimates but the bottom line meeting the same. It provides guidance for 2025.

PNW fourth-quarter earnings decrease year over year, while revenues increase. Total operating expenses also rise during the same period.

MRNA's earnings and revenues surpass estimates in the fourth quarter of 2024. The company reiterates 2025 total revenue guidance.

FSLR's fourth-quarter revenues beat the Zacks Consensus Estimate by 3%. The top line also increases 30.7% from the year-ago level.